Keppra is a brand name for levetiracetam. They contain the same active ingredient at the same strength, and generic levetiracetam works the same way in your body. The difference comes down to manufacturer, price, and inactive ingredients like fillers and dyes.
Brand Name vs. Generic
Levetiracetam is the drug itself. Keppra is the original brand name under which it was first sold. The FDA has approved levetiracetam for over 24 years, and it’s now available from multiple manufacturers as a generic. You may also see other brand names like Keppra XR and Elepsia XR (both extended-release versions) and Spritam (a tablet that dissolves on the tongue), but the active drug in all of them is levetiracetam.
Generic levetiracetam comes in the same forms as Keppra: immediate-release tablets (250, 500, 750, and 1000 mg), an oral liquid at 100 mg per milliliter, and extended-release tablets. Your pharmacy will typically dispense whichever version they stock unless your prescription specifies “brand name only.”
How the FDA Ensures They’re Equivalent
For any generic to reach the market, the FDA requires it to demonstrate bioequivalence to the brand-name version. That means the generic must deliver the active drug into your bloodstream at a rate and amount that falls within 80% to 125% of the brand-name product’s performance. In practice, most approved generics land much closer to 100% than those outer limits suggest. For drugs with a narrow margin between an effective dose and a harmful one, the FDA applies even tighter standards, though levetiracetam is not typically classified in that narrow-therapeutic-index category.
What Is Different Between Them
The active ingredient is identical, but inactive ingredients differ. Brand-name Keppra tablets contain fillers and coatings like colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, and specific colorants (indigo carmine for the 250 mg, iron oxide yellow for the 500 mg). Generic versions use their own combination of inactive ingredients to hold the tablet together, coat it, and give it color. These differences rarely matter, but if you have a known sensitivity or allergy to a specific dye or filler, it’s worth comparing the ingredient lists.
The liquid form of Keppra includes flavoring agents, glycerin, and preservatives like methylparaben. Generic liquid versions may use different flavoring or sweeteners, which can affect taste.
The Price Gap Is Significant
Brand-name Keppra costs roughly $810 for a 30-day supply without insurance. Generic levetiracetam for the same quantity (60 tablets of 500 mg) runs between $65 and $153 at retail, and discount programs can bring it as low as $6 to $7. That makes the generic anywhere from 5 to 100 times cheaper depending on where you fill it.
Switching From Brand to Generic
Levetiracetam is considered one of the safer antiseizure medications to switch between manufacturers. The UK’s NHS Specialist Pharmacy Service places it in “Category 3,” meaning switching is generally safe because the chance of clinically meaningful differences between products is extremely low. This is a different situation than drugs like phenytoin or carbamazepine, where even small absorption differences can cause problems.
That said, guidelines still recommend caution in certain situations. If your seizures are well controlled (especially if you’re seizure-free), some clinicians prefer not to introduce any unnecessary variables. The concern isn’t that the generic is inferior. It’s that any change, even a new pill shape or color, can sometimes cause confusion, anxiety, or accidental dosing errors. This is especially relevant for people with learning disabilities or conditions that make routine changes disruptive. If you’ve had problems after a previous manufacturer switch, that history matters and is worth mentioning to your pharmacist.
How Levetiracetam Works
Levetiracetam has an unusual mechanism compared to most seizure medications. Rather than blocking sodium channels or boosting the brain’s main calming chemical (as many older drugs do), it binds to a protein called SV2A that sits on the surface of tiny storage compartments inside nerve cells. These compartments release chemical messengers that excite neighboring neurons, and when levetiracetam latches onto SV2A, it reduces that excitatory signaling. This dampening effect is what prevents the runaway electrical activity that causes seizures.
Side Effects to Know About
Whether you take Keppra or generic levetiracetam, the side effect profile is the same because the active drug is the same. The most commonly discussed effects are behavioral and mood changes, sometimes called “Keppra rage” informally. In clinical trials, about 13% of patients reported behavioral symptoms like agitation, hostility, anxiety, or depression. In real-world use after the drug reached the market, studies have reported behavioral issues in anywhere from 6% to 31% of patients, a wide range that reflects differences in how studies defined and tracked these symptoms.
About 7% of patients in one large postmarketing study stopped taking levetiracetam specifically because of behavioral side effects. Among those who discontinued, depression and irritability were the most common reasons, followed by aggression and, less frequently, psychosis or hallucinations. A small number of patients experienced symptoms severe enough to be considered dangerous to themselves or others, including suicidal thoughts in three cases out of the 550 patients tracked.
These behavioral effects are not unique to the brand-name version. They are a property of the levetiracetam molecule itself, so switching to or from generic won’t eliminate them. Common physical side effects include drowsiness, dizziness, and fatigue, which often improve after the first few weeks of treatment.